TEMPLATE PRESS RELEASE
[INSERT SITE LETTERHEAD/LOGO]
Contact:
[SITE CONTACT]
[SITE NAME]
[PHONE]
[EMAIL]
For Immediate Release
[SITE NAME] Offers Patients the Latest Advances in Prostate Cancer Treatment Options -Including the Cancer Immunotherapy PROVENGE® (sipuleucel-T)
-- First in Class Therapy Designed to Stimulate a
Patient’s Own Immune System to Fight Cancer -[CITY, STATE ABBREVIATION, DATE] – [SITE NAME] is proud to now offer prostate cancer
patients one of the latest advances in treatment options, the first-in-class immunotherapy,
PROVENGE® (sipuleucel-T). PROVENGE is the only FDA-approved treatment for certain men
with advanced prostate cancer that uses the patient’s own immune system to fight the disease.
PROVENGE is designed to stimulate a patient’s immune system to identify and target prostate
cancer cells. Each dose is manufactured specifically for each patient using his own immune cells.
[INSERT A QUOTE FROM A PHYSICIAN AT YOUR SITE REGARDING YOUR ROLE IN
OFFERING PATIENTS THE LATEST PROSTATE CANCER TREATMENT ADVANCEMENTS]
PROVENGE is not a chemotherapy drug which uses chemicals to treat diseases, such as cancer,
and is different from hormone therapy which decreases the level of testosterone in the body.
PROVENGE is an immunotherapy that works by stimulating the natural ability of immune cells
already in the patient’s body and may help patients live longer. A complete course of
PROVENGE is three infusions, typically administered approximately two weeks apart, and the
most common side effects are primarily mild or moderate.
Indication
PROVENGE® (sipuleucel-T) is approved by the FDA as an autologous cellular immunotherapy for
the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone
refractory) prostate cancer.
Important Safety Information
PROVENGE is made from your own immune cells. Your cells will be collected at a cell collection
center approximately 3 days before each scheduled infusion of PROVENGE. There can be risks
associated with the cell collection process, which you should discuss with your doctor before
deciding to begin treatment with PROVENGE.
PROVENGE can cause serious reactions. In controlled clinical trials for the treatment of prostate
cancer, serious reactions reported in patients in the PROVENGE group included reactions
resulting from the infusion of the drug, which occurred within 1 day of infusion, and strokes.
Severe infusion reactions included chills, fever, fatigue, weakness, breathing problems (shortness
of breath, decreased oxygen level, and wheezing), dizziness, headache, high blood pressure,
P-A-08.10-045.02
muscle ache, nausea, and vomiting. Tell your doctor right away if you have breathing problems,
chest pains, racing heart or irregular heartbeats, dizziness, nausea, or vomiting after getting
PROVENGE , because any of these may be signs of heart or lung problems.
The most common side effects reported with PROVENGE were chills, fatigue, fever, back pain,
nausea, joint ache, and headache. These are not all the possible side effects of PROVENGE
treatment.
For more information on PROVENGE, please see the full Prescribing Information or call
1-800-707-0742.
About Prostate Cancer
According to the American Cancer Society, prostate cancer is the second most common cancer
in men in the U.S. and the second leading cause of cancer-related deaths in men. Each year one
in six men will be diagnosed with prostate cancer during his lifetime, and one in 36 will die from
the disease.
Individuals interested in learning whether PROVENGE is an appropriate treatment option should
contact [SITE CONTACT INFORMATION] or call 1-877-336-3736. For full Prescribing
Information, please visit www.PROVENGE.com.
About [SITE NAME]
[INSERT SITE BOILER PLATE]
For media/reporter inquiries, contact [INSERT SITE MEDIA CONTACT AND CONTACT
INFORMATION]
###
P-A-08.10-045.02